[HTML][HTML] Prognostic model for overall survival of head and neck cancer patients in the palliative phase
A Hoesseini, A Sewnaik, BN van den Besselaar… - BMC Palliative Care, 2024 - Springer
Background Patients with head and neck squamous cell carcinoma (HNSCC) enter the
palliative phase when cure is no longer possible or when they refuse curative treatment. The …
palliative phase when cure is no longer possible or when they refuse curative treatment. The …
Hematopoietic colony-stimulating factors in head and neck cancers: Recent advances and therapeutic challenges
G de Souza Vieira, T de Carvalho Kimura, JF Scarini… - Cytokine, 2024 - Elsevier
Colony-stimulating factors (CSFs) are key cytokines responsible for the production,
maturation, and mobilization of the granulocytic and macrophage lineages from the bone …
maturation, and mobilization of the granulocytic and macrophage lineages from the bone …
Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society …
Abstract Background For R/M HNSCC, the differences in prognosis and treatment options
between distant metastasis (DM) and locoregional recurrence, especially in the DM group …
between distant metastasis (DM) and locoregional recurrence, especially in the DM group …
[HTML][HTML] A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305
A Argiris, Y Flamand, P Savvides, JM Johnson… - European Journal of …, 2024 - Elsevier
Introduction For patients with recurrent or metastatic head and neck squamous cell
carcinoma (R/M HNSCC) periodic reassessment of prognostic factors provides valuable …
carcinoma (R/M HNSCC) periodic reassessment of prognostic factors provides valuable …
Aktivacija signalnog puta cGAS-STING u karcinomu grkljana
J Viculin - 2024 - repozitorij.mefst.unist.hr
Sažetak Zbog relativno niske stope odgovora i skromnih ishoda primjene imunoterapije
inhibitorima kontrolnih točaka u recidivirajućem ili metastatkom karcinomu grkljana …
inhibitorima kontrolnih točaka u recidivirajućem ili metastatkom karcinomu grkljana …
[PDF][PDF] Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer
AML BScMED, MD Christian von Buchwald - academia.edu
Background: Isolated regional recurrences following head-neck squamous-cell carcinomas
(HNSCC) are often accessible for curatively intended salvage treatment. Factors prognostic …
(HNSCC) are often accessible for curatively intended salvage treatment. Factors prognostic …